The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome

/ 2021, Educación y epidemiología, Publicaciones Científicas / Por

M. Gerde,E. Ibarra,R. Mac Kenzie,C. Fernandez Suarez,C. Heer,R. Alvarez,M. Iglesias,J. Balparda,E. Beruti and F. Rubinstein. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thrombosis Research. 2021;206:10.1016/j.thromres.2021.08.004.

Ir a la publicación